Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2025-12-24 @ 9:56 PM
NCT ID:
NCT04740632
Eligibility Criteria:
Inclusion Criteria:
* Adult mother of a patient \<12 years of age diagnosed with FA
Exclusion Criteria:
* Mother's age \<18 years
* Mother unable to understand Italian
* Mother suffering from chronic diseases
* Mother suffering from epilepsy
* Mother suffering from neoplasms
* Mother suffering from immunodeficiencies
* Mother suffering from chronic infections
* Mother suffering from autoimmune diseases
* Mother suffering from inflammatory bowel diseases
* Mother suffering from functional gastrointestinal disorders
* Mother suffering from celiac disease
* Mother suffering from genetic-metabolic diseases
* Mother suffering from tuberculosis
* Mother suffering from congenital heart disease
* Mother suffering from tuberculosis
* Mother suffering from cystic fibrosis
* Mother suffering from other chronic pulmonary diseases
* Mother suffering from major malformations
* Mother suffering from previous surgery of the cardiovascular / respiratory / gastrointestinal tract
* Mother suffering from diabetes
* Mother suffering from neuropsychiatric and neurological disorders
* Mother suffering from eosinophilic disorders of the gastrointestinal tract
* Mother not living with her child with FA
* Concomitant presence in the child with FA of chronic diseases
* Concomitant presence in the child with FA of epilepsy
* Concomitant presence in the child with FA of neoplasms
* Concomitant presence in the child with FA of immunodeficiencies
* Concomitant presence in the child with FA of chronic infections
* Concomitant presence in the child with FA of autoimmune diseases
* Concomitant presence in the child with FA of inflammatory bowel diseases
* Concomitant presence in the child with FA of functional gastrointestinal disorders
* Concomitant presence in the child with FA of celiac disease
* Concomitant presence in the child with FA of genetic-metabolic diseases
* Concomitant presence in the child with FA of tuberculosis
* Concomitant presence in the child with FA of congenital heart disease
* Concomitant presence in the child with FA of tuberculosis
* Concomitant presence in the child with FA of cystic fibrosis
* Concomitant presence in the child with FA of other chronic lung diseases
* Concomitant presence in the child with FA of major malformations
* Concomitant presence in the child with FA of previous surgeries of the cardiovascular / respiratory / gastrointestinal tract
* Concomitant presence in the child with FA of diabetes
* Concomitant presence in the child with FA of neuropsychiatric and neurological disorders
* Concomitant presence in the child with FA of eosinophilic diseases of the gastrointestinal tract
* Concomitant presence in the child with FA of allergic diseases other than FA.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04740632
Study Brief:
Protocol Section:
NCT04740632